Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

BACKGROUND AND PURPOSE: Risk factors for stroke are well-established in general populations but sparsely studied in individuals with impaired glucose tolerance. METHODS: We identified predictors of stroke among participants with impaired glucose tolerance in the Nateglinide and Valsartan in Impaire...

Detaylı Bibliyografya
Asıl Yazarlar:	Preiss, D, Giles, T, Thomas, L, Sun, J, Haffner, S, Holman, R, Standl, E, Mazzone, T, Rutten, G, Tognoni, G, Chiang, F, McMurray, J, Califf, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
Yazar:: Preiss, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
Yazar:: Califf, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Yazar:: Latini, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
Yazar:: Mcmurray, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
Yazar:: Currie, G, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
Yazar:: Krum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
Yazar:: Sharma, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
Yazar:: Bethel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
Yazar:: Bethel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach
Yazar:: Theodorakis, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
Yazar:: Hermans, M, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Early detection of impaired glucose tolerance in young adults
Yazar:: May, Khin Soe, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Yazar:: Gerstein, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
Yazar:: Califf, R, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
Yazar:: Yates, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
Yazar:: Yates, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
Yazar:: Wamil, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
Yazar:: Holman, R
Baskı/Yayın Bilgisi: (1996)

Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
Yazar:: Shen, L, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Diet and other health-related behaviors of individuals with impaired glucose tolerance, cardiovascular disease (CVD) or CVD risk: A global view from the NAVIGATOR study
Yazar:: Bales, C, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The role of nicotinamide nucleotide transhydrogenase in insulin secretion and impaired glucose tolerance
Yazar:: Freeman, H, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
Yazar:: Page, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Role of the transcription factor sox4 in insulin secretion and impaired glucose tolerance.
Yazar:: Goldsworthy, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
Yazar:: Shen, L, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.
Yazar:: McLellan, J, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

GLUCOSE-TOLERANCE AND BETA-CELL FUNCTION ASSESSED BY CONTINUOUS INFUSION OF GLUCOSE AND ORAL GLUCOSE-TOLERANCE TEST
Yazar:: Levy, J, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function.
Yazar:: Cook, J, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Prevalence and pathophysiology of impaired glucose tolerance in three different high-risk white groups.
Yazar:: Page, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
Yazar:: Dos Santos, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Changes in forearm blood flow at elevated ambient temperature and their role in the apparent impairment of glucose tolerance.
Yazar:: Frayn, K, ve diğerleri
Baskı/Yayın Bilgisi: (1989)

Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular risk.
Yazar:: Bowman, L, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Yazar:: Xu, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Baskı/Yayın Bilgisi: (2008)

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
Yazar:: Xu, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Histological features of symptomatic carotid plaques in patients with impaired glucose tolerance and diabetes (oxford plaque study).
Yazar:: Redgrave, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Evaluation of a self-administered oral glucose tolerance test
Yazar:: Bethel, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Microbial-host co-metabolites are prodromal markers predicting phenotypic heterogeneity in behavior, obesity, and impaired glucose tolerance
Yazar:: Dumas, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
Yazar:: Mc Morrow, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)